About Vytrus Biotech
Vytrus Biotech is a company based in Terrassa (Spain) founded in 2009 by Albert Jane Font and Oscar Exposito Tarres. Vytrus Biotech has raised $3.75 million across 3 funding rounds from investors including GVC Gaesco, Catalan Institute of Finance and Capital Cell. Vytrus Biotech offers products and services including Clarivine™, Baolift™, Photobiome™, and Elaya Renova™. Vytrus Biotech operates in a competitive market with competitors including Insempra, Naturex, Sophim, Beraca Natural Ingredients and Mibelle Biochemistry, among others.
- Headquarter Terrassa, Spain
- Founders Albert Jane Font, Oscar Exposito Tarres
-
Sectors
Chemicals & Materials
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
$5.24 M (USD)35as on Dec 31, 2024
-
Net Profit
$1.06 M (USD)87.36as on Dec 31, 2024
-
EBITDA
$1.81 M (USD)63.58as on Dec 31, 2024
-
Total Equity Funding
$3.75 M (USD)
in 3 rounds
-
Latest Funding Round
$2.49 M (USD), Series A
May 27, 2024
-
Investors
GVC Gaesco
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vytrus Biotech
Vytrus Biotech offers a comprehensive portfolio of products and services, including Clarivine™, Baolift™, Photobiome™, and Elaya Renova™.
Promotes skin longevity with fasting-mimicking effects
Enhances skin firmness for a lifting effect
Protects skin microbiota from photoaging
Boosts hair anchoring and scalp regeneration
People of Vytrus Biotech
Unlock access to complete
Unlock access to complete
Funding Insights of Vytrus Biotech
Vytrus Biotech has successfully raised a total of $3.75M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $2.49 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Vytrus Biotech
Vytrus Biotech has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include GVC Gaesco, Catalan Institute of Finance and Capital Cell.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investment fund
|
Locked | Locked | Locked | |
|
Delivers an online trading platform for accessing multiple markets efficiently.
|
Locked | Locked | Locked | |
|
Capital Cell is recognized as a leading alternative investment platform focused on biotechnology and life sciences companies.
|
Locked | Locked | Locked |
Investor details for Vytrus Biotech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vytrus Biotech
Investment portfolio details for Vytrus Biotech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vytrus Biotech
Detailed financials for Vytrus Biotech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vytrus Biotech Comparisons
Peer comparison for Vytrus Biotech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vytrus Biotech
Vytrus Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insempra, Naturex, Sophim, Beraca Natural Ingredients and Mibelle Biochemistry, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sustainable ingredients and materials for biotechnology are manufactured.
|
|
| Locked | Locked | Locked |
Natural extracts are manufactured for colorings, flavorings, and nutraceuticals.
|
|
| Locked | Locked | Locked |
Manufacturer of squalane products
|
|
| Locked | Locked | Locked |
Organic natural ingredients are retailed by Beraca from Brazil.
|
|
| Locked | Locked | Locked |
Provides innovative active ingredients for cosmetics and food health sectors globally.
|
Detailed competitors of Vytrus Biotech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vytrus Biotech
Complete news archive for Vytrus Biotech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vytrus Biotech
Vytrus Biotech was founded in 2009 and raised its 1st funding round 8 years after it was founded.
Vytrus Biotech is headquartered in Terrassa, Spain. It is registered at Terrassa, Catalonia, Spain.
Albert Jane Font is the current CEO of Vytrus Biotech. They have also founded this company.
Vytrus Biotech is a funded company, having raised a total of $3.75M across 3 funding rounds to date.
Annual revenue of Vytrus Biotech is $5.24M as on Dec 31, 2024.
Vytrus Biotech was founded in 2009 and is based in Terrassa, Spain. Operations focus on the biotechnology sector, where plant cell-based active ingredients for cosmetic products are developed. Various technologies, including plasma cell factors, are utilized in the production process. The company serves the cosmetics industry by providing these specialized ingredients from plant sources.
Vytrus Biotech offers Clarivine™, Baolift™, Photobiome™, and Elaya Renova™.
Vytrus Biotech has 3 investors. Key investors include GVC Gaesco, Catalan Institute of Finance, and Capital Cell.